Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2009 by Chung-Ang University.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Gyeongsang National University Hospital
Information provided by:
Chung-Ang University
ClinicalTrials.gov Identifier:
NCT01170104
First received: July 23, 2010
Last updated: June 22, 2011
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)